Literature DB >> 15849829

Role of AFP mRNA expression in peripheral blood as a predictor for postsurgical recurrence of hepatocellular carcinoma: a systematic review and meta-analysis.

Xiang Ding1, Lian-Yue Yang, Geng-Wen Huang, Jian-Qing Yang, He-Li Liu, Wei Wang, Ji-Xiang Peng, Jie-Quan Yang, Yi-Ming Tao, Zhi-Gang Chang, Xiu-Shou Ling.   

Abstract

AIM: To identify the role of alpha-fetoprotein (AFP) mRNA expression in peripheral blood one week after surgery as a predictor for recurrence of hepatocellular carcinoma (HCC).
METHODS: Published studies fulfilling the selection criteria were identified by searching several databases online. After a methodology assessment using a quality scale designed by European Lung Cancer Working Party, data in each research were aggregated by means of meta-analysis.
RESULTS: Altogether 368 cases were included in the 9 selected studies, which fulfilled the selection criteria. The quality scores ranged from 35% to 84% with a median score of 55%. The 'design' subscore had the lowest median value (38%). By aggregating the data, a high chi2 value (77.576) was presented. The fail-safe number was 136 and 64 for P = 0.05 and 0.01, respectively.
CONCLUSION: AFP mRNA expression in peripheral blood 1 wk after surgery correlated with the recurrence of HCC and was a good predictor for tumor recurrence.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849829      PMCID: PMC4305761          DOI: 10.3748/wjg.v11.i17.2656

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

1.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

Authors:  A Aupérin; R Arriagada; J P Pignon; C Le Péchoux; A Gregor; R J Stephens; P E Kristjansen; B E Johnson; H Ueoka; H Wagner; J Aisner
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

2.  A marker for predictions of HCC recurrence postresection?

Authors:  Laurie Blendis; Florence Wong
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

3.  Clinical significance of alpha-fetoprotein mRNA during perioperative period in HCC.

Authors:  N Okuda; A Nakao; S Takeda; K Oshima; N Kanazumi; T Nonami; T Kurokawa; H Takagi
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

4.  Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis.

Authors:  I H Wong; W Y Lau; T Leung; W Yeo; P J Johnson
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

5.  Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.

Authors:  E Steels; M Paesmans; T Berghmans; F Branle; F Lemaitre; C Mascaux; A P Meert; F Vallot; J J Lafitte; J P Sculier
Journal:  Eur Respir J       Date:  2001-10       Impact factor: 16.671

6.  alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.

Authors:  Masayoshi Ijichi; Tadatoshi Takayama; Masayuki Matsumura; Yasushi Shiratori; Masao Omata; Masatoshi Makuuchi
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

7.  Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells.

Authors:  M Louha; J Nicolet; H Zylberberg; A Sabile; C Vons; G Vona; K Poussin; M Tournebize; F Capron; S Pol; D Franco; B Lacour; C Bréchot; P Paterlini-Bréchot
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

8.  Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future.

Authors:  R D Riley; K R Abrams; A J Sutton; P C Lambert; D R Jones; D Heney; S A Burchill
Journal:  Br J Cancer       Date:  2003-04-22       Impact factor: 7.640

9.  Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma.

Authors:  M Matsumura; Y Niwa; N Kato; Y Komatsu; S Shiina; T Kawabe; T Kawase; H Toyoshima; M Ihori; Y Shiratori
Journal:  Hepatology       Date:  1994-12       Impact factor: 17.425

Review 10.  Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis.

Authors:  A P Meert; M Paesmans; T Berghmans; B Martin; C Mascaux; F Vallot; J M Verdebout; J J Lafitte; J P Sculier
Journal:  BMC Cancer       Date:  2001-06-19       Impact factor: 4.430

View more
  8 in total

1.  Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Lorenzo Andreana; Graziella Isgrò; Maria Pleguezuelo; Giacomo Germani; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2009-10-31

2.  Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis.

Authors:  Chen Zhong; Jin-Dao Wu; Ming-Ming Fang; Li-Yong Pu
Journal:  Tumour Biol       Date:  2015-04-29

Review 3.  Diagnosis of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Shahid A Khan; Edward L S Leen; Imam Waked; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

Review 4.  Serum tumor markers for detection of hepatocellular carcinoma.

Authors:  Lin Zhou; Jia Liu; Feng Luo
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

5.  Effect of Bcl-2 and Bax on survival of side population cells from hepatocellular carcinoma cells.

Authors:  Jing Fan; Ren Li; Rui Zhang; Hai-Liang Liu; Ning Zhang; Fu-Qing Zhang; Ke-Feng Dou
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

6.  Biomarkers for hepatocellular carcinoma.

Authors:  Tara Behne; M Sitki Copur
Journal:  Int J Hepatol       Date:  2012-05-10

Review 7.  Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.

Authors:  Fabio Grizzi; Barbara Franceschini; Cody Hamrick; Eldo E Frezza; Everardo Cobos; Maurizio Chiriva-Internati
Journal:  J Transl Med       Date:  2007-01-23       Impact factor: 5.531

8.  The application of a three-step serum proteome analysis for the discovery and identification of novel biomarkers of hepatocellular carcinoma.

Authors:  Asako Kimura; Kazuyuki Sogawa; Mamoru Satoh; Yoshio Kodera; Osamu Yokosuka; Takeshi Tomonaga; Fumio Nomura
Journal:  Int J Proteomics       Date:  2012-08-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.